AtaGenix Laboratories
Release time: 2024-11-13 View volume: 2156
Service Overview — AtaGenix’s mammalian cell expression platform (HEK293 / CHO-S transient; CHO-K1 / DG44 stable) delivers properly folded, glycosylated recombinant proteins for basic research, drug development, and diagnostic reagent production. 5,000+ projects delivered, 200+ stable cell lines constructed, ISO 9001 & ISO 13485 certified.
High Expression Efficiency
Optimized expression systems scalable from mL to 100 L transient and up to 200 L+ serum-free suspension batches. In-house high-yield protocols increase output 3–6× over standard methods.
Native Post-Translational Modifications
Mammalian cell systems preserve glycosylation, phosphorylation, and disulfide bonding, ensuring biological activity consistent with native proteins.
Flexible Customization
Multiple expression vectors, tag options (His, Fc, GST, FLAG), and purification protocols tailored to target protein characteristics and downstream application requirements.
1
Project Evaluation
Custom expression strategy & feasibility analysis based on target protein information.
2
Gene Cloning & Vector
Gene optimization, cloning into optimized vectors, condition fine-tuning.
3
Transfection & Expression
Advanced transfection into HEK293 or CHO cells with optimized high-yield conditions.
4
Purification & QC
Multi-step purification, SDS-PAGE, SEC-HPLC, endotoxin testing (<0.1 EU/mL).
AtaGenix mammalian cell expression services support drug target validation, antibody generation and immunization, vaccine antigen production, structural biology research, and diagnostic reagent manufacturing. Proteins cited in Advanced Materials (IF 27.4), Immunity (IF 25.5), Nature Communications (IF 14.7), and Molecular Psychiatry (IF 9.6).
Ready to discuss your mammalian expression project? Share your target protein information and we’ll design a customized strategy within 24 hours.
Talk to Technical SupportResponse within 24 hours
Contact Us
+86-27-6552-3339
info@atagenix.com
Building C, R & D Building, No. 666, Shendun 4th Road, Donghu New Technology Development Zone, Wuhan

